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Abstract
Familial hypercholesterolemia is a single gene disorder with an autosomal dominant pattern of
inheritance. Here we report an 18 year old South Indian girl who presented with myocardial
infarction. She had xanthomas and an elevated serum low density lipoprotein cholesterol (LDL-C).
Her mother and maternal uncle had died at a young age due to myocardial infarction. Her only
sibling, 15 year old younger sister also had xanthomas and an elevated LDL-C. This report is to
emphasise the need to clinically recognize xanthomas and its association with elevated LDL-C,
premature atherosclerosis and familial inheritance. Early diagnosis and early initiation of treatment
will save the affected individual and the other family members.
Background
Muller et el in the year 1938 reported a familial clustering
of xanthoma, high cholesterol and myocardial infarction
[1]. In 1960, Khachadurian et al demonstrated that this
clinical association termed familial hypercholesterolemia
(FH) is a single gene disorder with an autosomal domi-
nant pattern of inheritance [2]. Further studies identified
the association between improper metabolism of LDL and
FH and that mutation in the LDL receptor gene (LDLR)
located on chromosome 19 was responsible for this disor-
der [3-5]. FH is of 2 types, a homozygous type where both
LDL receptor alleles are defective due to mutation and has
a prevalence of 1 in 1 million persons world wide [6]. In
the heterozygous type only one LDL receptor allele is a
mutant and is much more common with a prevalence of
1 in 500 persons worldwide [6]. Here we report one such
family from South India with features of premature
atherosclerosis, high serum levels of LDL cholesterol and
multiple xanthomas.
Case presentation
An 18 year old South Indian girl presented to the emer-
gency department of a tertiary care hospital with com-
plaints of anginal chest pain and dyspnea for 4 hours
duration. She was a tailor by occupation. She had no past
history of diabetes mellitus, hypothyroidism, coronary
artery disease, hepatic disease or renal disease. She was
unmarried and had regular menstrual cycles. She weighed
54 kgs and was 157 cms tall. Her body mass index was 22
kg/m2. General physical examination revealed multiple
soft subcutaneous swellings over her hand, knuckles,
achilles tendon, wrist and ankle suggestive of xanthomas
(Figure 1). She had corneal arcus (Figure 2). Her systems
exam revealed tachycardia, S3 gallop on cardiac ausculta-
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tion and bibasilar crackles in the lungs. Electrocardiogram
was consistent with acute anterior wall myocardial infarc-
tion. Echocardiogram showed a hypokinetic anterior wall
of the heart, with a left ventricular ejection fraction of
30%, aortic valves were normal with no evidence of valvu-
lar stenosis. She was consequently thrombolysed with tis-
sue plasminogen activator (TPA) for her acute anterior
wall myocardial infarction and her pulmonary edema was
managed. Her labs revealed normal blood counts and
renal functions. Her fasting lipid profile (table 1) showed
a high total cholesterol and LDL cholesterol with normal
triglycerides. Her angiogram showed 60% stenosis of the
left anterior descending coronary artery and a 30% steno-
sis of the left circumflex coronary artery. The biopsy of one
of the swellings (the swelling in her wrist) revealed lipid
laden foam cells with large areas of cholesterol clefts (fig-
ure 3), suggestive of a xanthoma. On further questioning
she gave a family history of accelerated atherosclerosis.
Her mother and her maternal uncle had died due to myo-
cardial infarction at the age of 23 years and 19 yrs respec-
tively and that her mother also had similar xanthomas.
Her only sibling her younger sister (15 yrs old) in addition
to having xanthomas, had a lipid profile (Table 1) consist-
ent with a high total cholesterol and LDL cholesterol with
normal triglycerides. Her pedigree chart can be seen in Fig-
ure 4.
She was initially treated with atorvastatin 80 mg once
daily with ezetimibe 10 mg daily. Her LDL-C levels meas-
ured after 8 weeks was still 538 mg/dl (table 2). Hence in
view of persistent LDL-C elevation inspite of maximal
drug therapy for 8 weeks, the patient was advised LDL
apheresis and was referred to a specialist center. On follow
up, after 3 sessions of LDL apheresis (one session every
Xanthomas Figure 1
Xanthomas. Photograph of patient's hands showing multiple xanthomas.Cases Journal 2008, 1:71 http://www.casesjournal.com/content/1/1/71
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week), her LDL-C levels were 165 mg/dl (table 2). In addi-
tion to weekly LDL apheresis she is also treated with ator-
vastatin 40 mg and ezetimibe 10 mg daily.
Discussion
Our patient had myocardial infarction at a young age of
18 yrs with a lipid profile comprising a high LDL-C with
normal triglycerides. She had xanthomas and corneal
arcus. Her family history was classical with 2 generations
being affected with premature atherosclerosis and both
male and female individuals being affected equally.
Hence this suggests an autosomal dominant disorder.
Simon Broome's diagnostic criteria for familial hypercho-
lesterolemia says a definite diagnosis of familial hyperc-
holesterolemia can be made if either the total cholesterol
concentration is above 7.5 mmol/liter in adults or the low
density lipoprotein cholesterol concentration is above 4.9
mmol/liter in adults and if tendinous xanthomas were
present in the patient or a first-degree relative [7,8]. Our
patient had total cholesterol of 16.8 mmol/l and a LDL-C
of 14.6 mmol/l. She, her mother and her sister had xan-
thomas. Hence this confirms the diagnosis of familial
hypercholesterolemia in our patient. She should have had
the homozygous type of FH as the heterozygous type
presents much later in adult life with coronary artery dis-
ease and LDL-C levels are generally less than 400 mg/dl
[6].
Treatment options available for homozygous FH are lipid
lowering drugs like statins, bile acid sequestrants, apher-
esis and liver transplantation [6]. Lipid lowering drugs
only result in modest reduction in LDL-C levels and
apheresis is generally required when evidence of athero-
sclerosis is present. As liver is the most important tissue
for removing circulating LDL, liver transplantation is an
effective treatment option in this disorder. Our patient's
LDL-C was refractory to drug therapy and hence she was
initiated on LDL apheresis. Her response was satisfactory
to this modality of treatment.
Conclusion
Clinical identification of xanthomas and knowledge of its
association with coronary artery disease is essential for
every physician as early diagnosis and treatment can pre-
vent premature deaths due to MI. Also all the relatives in
the family should be screened for dyslipidemia.
Patient's perspective
I have been having these swellings in my body for the last
7 years. I would have visited many doctors for various
Pedigree chart Figure 4
Pedigree chart.
Corneal arcus Figure 2
Corneal arcus. Photograph of patient's eyes showing cor-
neal arcus, white rim coating the limbus in both eyes.
Histology of Xanthoma Figure 3
Histology of Xanthoma. Histology picture of xanthoma 
showing lipid laden foam cells with large areas of cholesterol 
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common ailments. Had they recognized this disorder in
me much earlier I would not have had a heart attack.
Atleast my sister will benefit as she has been diagnosed to
have this disease and treatment will soon be initiated.
After I get married I will also be careful with my children
as I understand that they are also prone for this disease.
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Table 1: Fasting lipid profile values of the patient and her sister
Patient's values Patient's sister's values
mg/dl mmol/l mg/dl mmol/l
Total cholesterol 657 mg/dl 16.8 mmol/l 630 mg/dl 16.15 mmol/l
LDL-C 572 mg/dl 14.6 mmol/l 554 mg/dl 14.2 mmol/l
HDL-C 61 mg/dl 1.6 mmol/l 50 mg/dl 1.3 mmol/l
Triglycerides 122 mg/dl 1.4 mmol/l 130 mg/dl 1.5 mmol/l
Table 2: Patient's lipid levels after treatment
After 8 weeks therapy with maximal lipid lowering drugs After 3 sessions of LDL apheresis
Total cholesterol 617 mg/dl 230 mg/dl
LDL-C 538 mg/dl 165 mg/dl
HDL-C 52 mg/dl 41 mg/dl
Triglycerides 133 mg/dl 120 mg/dl